Skip to main content

Watson welcomes Bodine to board of directors


MORRISTOWN, N.J. Watson Pharmaceuticals, a leader in generic and specialty branded pharmaceuticals, announced the addition of Christopher Bodine to its board of directors, effective immediately.

Bodine brings with him 36 years of experience in the chain drug industry with two of the nation’s leading retail and healthcare companies.

"Chris is a terrific addition to our board of directors, and we are extremely pleased to bring his unique customer insights and perspective to Watson," said Paul Bisaro, Watson president and CEO. "We look forward to his counsel as Watson embarks on its new global challenges, as well as the guidance and support that he can bring to our distribution business."

Bodine retired from CVS Caremark in 2009 after 24 years with the company. For years, he has been active in the industry as a member of several boards and committees. In 2005, he was recognized by Mass Market Retailers magazine as the publication’s Top Retail Merchandiser and was named one of Drug Store News’ “Five People Who Made a Difference” in retail.

This ad will auto-close in 10 seconds